Applied DNA Sciences Inc (APDN) - Total Assets
Based on the latest financial reports, Applied DNA Sciences Inc (APDN) holds total assets worth $9.93 Million USD as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore APDN operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Applied DNA Sciences Inc - Total Assets Trend (2001–2025)
This chart illustrates how Applied DNA Sciences Inc's total assets have evolved over time, based on quarterly financial data. See Applied DNA Sciences Inc (APDN) shareholders funds for net asset value and shareholders' equity analysis.
Applied DNA Sciences Inc - Asset Composition Analysis
Current Asset Composition (September 2025)
Applied DNA Sciences Inc's total assets of $9.93 Million consist of 50.4% current assets and 49.6% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 37.6% |
| Accounts Receivable | $237.40K | 5.4% |
| Inventory | $84.10K | 1.9% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2001–2025)
This chart illustrates how Applied DNA Sciences Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see APDN market cap overview.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Applied DNA Sciences Inc's current assets represent 50.4% of total assets in 2025, a decrease from 100.0% in 2001.
- Cash Position: Cash and equivalents constituted 37.6% of total assets in 2025, down from 100.0% in 2001.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2001.
- Asset Diversification: The largest asset category is accounts receivable at 5.4% of total assets.
Applied DNA Sciences Inc Competitors by Total Assets
Key competitors of Applied DNA Sciences Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Voxel S.A.
WAR:VOX
|
Poland | zł706.69 Million |
|
SCOPE FLUIDICS SA ZY-10
F:S84
|
Germany | €195.94 Million |
|
Genoray Co. Ltd
KQ:122310
|
Korea | ₩131.23 Billion |
|
Bcal Diagnostics Ltd
AU:BDX
|
Australia | AU$7.17 Million |
|
Check-Cap Ltd
F:7CC
|
Germany | €7.49 Million |
|
Sonic Healthcare Ltd
AU:SHL
|
Australia | AU$17.03 Billion |
|
Integral Diagnostics Ltd
AU:IDX
|
Australia | AU$1.43 Billion |
|
Australian Clinical Labs Ltd
AU:ACL
|
Australia | AU$562.50 Million |
Applied DNA Sciences Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.76 | 3.91 | 2.13 |
| Quick Ratio | 2.60 | 3.76 | 2.01 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $3.59 Million | $8.82 Million | $4.81 Million |
Applied DNA Sciences Inc - Advanced Valuation Insights
This section examines the relationship between Applied DNA Sciences Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.85 |
| Latest Market Cap to Assets Ratio | 0.90 |
| Asset Growth Rate (YoY) | -65.3% |
| Total Assets | $4.44 Million |
| Market Capitalization | $3.99 Million USD |
Valuation Analysis
Near Book Valuation: The market values Applied DNA Sciences Inc's assets close to their book value (0.90x), suggesting investors view the company's assets at approximately fair value.
Significant Asset Reduction: Applied DNA Sciences Inc's assets decreased by 65.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Applied DNA Sciences Inc (2001–2025)
The table below shows the annual total assets of Applied DNA Sciences Inc from 2001 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-09-30 | $4.44 Million | -65.30% |
| 2024-09-30 | $12.79 Million | -6.32% |
| 2023-09-30 | $13.65 Million | -38.69% |
| 2022-09-30 | $22.27 Million | +54.44% |
| 2021-09-30 | $14.42 Million | +27.12% |
| 2020-09-30 | $11.34 Million | +218.15% |
| 2019-09-30 | $3.56 Million | -36.73% |
| 2018-09-30 | $5.63 Million | -30.91% |
| 2017-09-30 | $8.15 Million | -47.62% |
| 2016-09-30 | $15.57 Million | +0.07% |
| 2015-09-30 | $15.55 Million | +343.64% |
| 2014-09-30 | $3.51 Million | -58.14% |
| 2013-09-30 | $8.37 Million | +520.86% |
| 2012-09-30 | $1.35 Million | -61.50% |
| 2011-09-30 | $3.50 Million | +147.90% |
| 2010-09-30 | $1.41 Million | -6.22% |
| 2009-09-30 | $1.51 Million | -18.40% |
| 2008-09-30 | $1.85 Million | -23.42% |
| 2007-09-30 | $2.41 Million | -48.43% |
| 2006-09-30 | $4.68 Million | -49.07% |
| 2005-09-30 | $9.18 Million | +11146.61% |
| 2004-09-30 | $81.65K | -60.63% |
| 2003-09-30 | $207.36K | +153500.74% |
| 2001-09-30 | $135.00 | -- |
About Applied DNA Sciences Inc
Applied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment develops… Read more